Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques

Citation
Je. Loomis-huff et al., Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques, VACCINE, 19(32), 2001, pp. 4865-4873
Citations number
73
Categorie Soggetti
Veterinary Medicine/Animal Health",Immunology
Journal title
VACCINE
ISSN journal
0264410X → ACNP
Volume
19
Issue
32
Year of publication
2001
Pages
4865 - 4873
Database
ISI
SICI code
0264-410X(20010914)19:32<4865:IOADVA>2.0.ZU;2-H
Abstract
Herpes B virus (Cercopithecine herpesvirus 1) is endemic in captive macaque populations and poses a serious threat to humans who work with macaques or their tissues. A vaccine that could prevent or limit B virus infection in macaques would lessen occupational risk. To that end, a DNA vaccine plasmid expressing the B virus glycoprotein B (gB) was constructed and tested for immunogenicity in mice and macaques. Intramuscular (IM) or intradermal (ID) immunization in mice elicited antibodies to gB that were relatively stable over time and predominately of the IgG2a isotype. Five juvenile macaques w ere immunized by either IM + ID (n = 2) or IM (n = 3) routes, with two boos ter immunizations at 10 and 30 weeks. All five animals developed antibodies to B virus gB, with detectable neutralizing activity in the IM + ID immuni zed animals. These results demonstrated that DNA immunization can be used t o generate an immune response against a B virus glycoprotein in uninfected macaques. (C) 2001 Elsevier Science Ltd. All rights reserved.